Author Info: (1) Department of Microbiology & Immunology, Columbia University, New York, NY, USA. Herbert Irving Comprehensive Cancer Center, Vagelos College of Physicians and Surgeons, Columbi

Author Info: (1) Department of Microbiology & Immunology, Columbia University, New York, NY, USA. Herbert Irving Comprehensive Cancer Center, Vagelos College of Physicians and Surgeons, Columbia University, New York, NY, USA. (2) Department of Microbiology & Immunology, Columbia University, New York, NY, USA. Herbert Irving Comprehensive Cancer Center, Vagelos College of Physicians and Surgeons, Columbia University, New York, NY, USA. (3) Department of Microbiology & Immunology, Columbia University, New York, NY, USA. (4) Department of Microbiology & Immunology, Columbia University, New York, NY, USA. (5) Department of Microbiology & Immunology, Columbia University, New York, NY, USA. (6) Herbert Irving Comprehensive Cancer Center, Vagelos College of Physicians and Surgeons, Columbia University, New York, NY, USA. Division of Digestive and Liver Diseases, Department of Medicine, Vagelos College of Physicians and Surgeons, Columbia University Irving Medical Center, New York, NY, USA. (7) Herbert Irving Comprehensive Cancer Center, Vagelos College of Physicians and Surgeons, Columbia University, New York, NY, USA. Division of Digestive and Liver Diseases, Department of Medicine, Vagelos College of Physicians and Surgeons, Columbia University Irving Medical Center, New York, NY, USA. (8) Department of Biological Sciences, Columbia University, New York, NY, USA. (9) Department of Microbiology & Immunology, Columbia University, New York, NY, USA. Herbert Irving Comprehensive Cancer Center, Vagelos College of Physicians and Surgeons, Columbia University, New York, NY, USA. (10) Department of Microbiology & Immunology, Columbia University, New York, NY, USA. (11) Department of Microbiology & Immunology, Columbia University, New York, NY, USA. (12) Department of Biological Sciences, Department of Chemistry, and Department of Pathology and Cell Biology, Herbert Irving Comprehensive Cancer Center, Irving Institute for Cancer Dynamics, Digestive and Liver Disease Research Center, Columbia University, New York, NY, USA. (13) Department of Environmental Science and Technology, Faculty of Engineering, Shinshu University, Nagano, Japan. (14) Herbert Irving Comprehensive Cancer Center, Vagelos College of Physicians and Surgeons, Columbia University, New York, NY, USA. Department of Biomedical Engineering, Columbia University, New York, NY, USA. Data Science Institute, Columbia University, New York, NY, USA. (15) Department of Microbiology & Immunology, Columbia University, New York, NY, USA. na2697@cumc.columbia.edu. Herbert Irving Comprehensive Cancer Center, Vagelos College of Physicians and Surgeons, Columbia University, New York, NY, USA. na2697@cumc.columbia.edu.

Author Info: (1) Department of Biotherapy, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu 610041, China. (2) Department of Biotherapy, Ca

Author Info: (1) Department of Biotherapy, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu 610041, China. (2) Department of Biotherapy, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu 610041, China. (3) Department of Biotherapy, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu 610041, China. (4) Department of Oncology, West China Hospital, Sichuan University, Sichuan University West China Hospital Guang'an Hospital, Guang'an People's Hospital, Guang'an 638000, China. (5) Department of Biotherapy, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu 610041, China. (6) Department of Biotherapy, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu 610041, China. (7) Department of Biotherapy, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu 610041, China. (8) Department of Biotherapy, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu 610041, China. Electronic address: ping.cheng@foxmail.com. (9) Department of Biotherapy, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu 610041, China. Electronic address: liujiyan1972@163.com.

Author Info: (1) Division of Immuno-Oncology, Lund Stem Cell Center, Lund University, Lund, Sweden; Wallenberg Centre for Molecular Medicine, Lund University, Lund, Sweden; Science for Life Lab

Author Info: (1) Division of Immuno-Oncology, Lund Stem Cell Center, Lund University, Lund, Sweden; Wallenberg Centre for Molecular Medicine, Lund University, Lund, Sweden; Science for Life Laboratory (SciLifeLab), Lund University, Lund, Sweden. (2) Division of Immuno-Oncology, Lund Stem Cell Center, Lund University, Lund, Sweden; Wallenberg Centre for Molecular Medicine, Lund University, Lund, Sweden; Science for Life Laboratory (SciLifeLab), Lund University, Lund, Sweden. (3) Division of Immuno-Oncology, Lund Stem Cell Center, Lund University, Lund, Sweden; Wallenberg Centre for Molecular Medicine, Lund University, Lund, Sweden; Science for Life Laboratory (SciLifeLab), Lund University, Lund, Sweden. (4) Division of Immuno-Oncology, Lund Stem Cell Center, Lund University, Lund, Sweden; Wallenberg Centre for Molecular Medicine, Lund University, Lund, Sweden; Science for Life Laboratory (SciLifeLab), Lund University, Lund, Sweden. (5) Division of Immuno-Oncology, Lund Stem Cell Center, Lund University, Lund, Sweden; Wallenberg Centre for Molecular Medicine, Lund University, Lund, Sweden; Science for Life Laboratory (SciLifeLab), Lund University, Lund, Sweden; State Key Laboratory of Systems Medicine for Cancer, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. (6) Division of Immuno-Oncology, Lund Stem Cell Center, Lund University, Lund, Sweden; Wallenberg Centre for Molecular Medicine, Lund University, Lund, Sweden; Science for Life Laboratory (SciLifeLab), Lund University, Lund, Sweden. (7) Division of Immuno-Oncology, Lund Stem Cell Center, Lund University, Lund, Sweden; Wallenberg Centre for Molecular Medicine, Lund University, Lund, Sweden; Science for Life Laboratory (SciLifeLab), Lund University, Lund, Sweden. (8) Division of Immuno-Oncology, Lund Stem Cell Center, Lund University, Lund, Sweden; Wallenberg Centre for Molecular Medicine, Lund University, Lund, Sweden; Science for Life Laboratory (SciLifeLab), Lund University, Lund, Sweden. (9) Division of Immuno-Oncology, Lund Stem Cell Center, Lund University, Lund, Sweden; Wallenberg Centre for Molecular Medicine, Lund University, Lund, Sweden; Science for Life Laboratory (SciLifeLab), Lund University, Lund, Sweden. (10) Division of Immuno-Oncology, Lund Stem Cell Center, Lund University, Lund, Sweden; Wallenberg Centre for Molecular Medicine, Lund University, Lund, Sweden; Science for Life Laboratory (SciLifeLab), Lund University, Lund, Sweden. (11) Division of Immuno-Oncology, Lund Stem Cell Center, Lund University, Lund, Sweden; Wallenberg Centre for Molecular Medicine, Lund University, Lund, Sweden; Science for Life Laboratory (SciLifeLab), Lund University, Lund, Sweden. (12) Department of Clinical Sciences, Division of Oncology and Pathology, Lund University Cancer Center, Lund University, Lund, Sweden. (13) Department of Clinical Sciences, Division of Oncology and Pathology, Lund University Cancer Center, Lund University, Lund, Sweden. (14) Department of Clinical Sciences, Division of Oncology and Pathology, Lund University Cancer Center, Lund University, Lund, Sweden; Asgard Therapeutics AB, Medicon Village, Lund, Sweden. (15) Asgard Therapeutics AB, Medicon Village, Lund, Sweden. (16) Asgard Therapeutics AB, Medicon Village, Lund, Sweden. (17) Division of Immuno-Oncology, Lund Stem Cell Center, Lund University, Lund, Sweden; Wallenberg Centre for Molecular Medicine, Lund University, Lund, Sweden; Science for Life Laboratory (SciLifeLab), Lund University, Lund, Sweden. (18) Department of Clinical Sciences, Lund University, SkŒne university hospital, Lund, Sweden. (19) Department of Clinical Sciences, Lund University, SkŒne university hospital, Lund, Sweden. (20) Department of Clinical Sciences, Lund University, SkŒne university hospital, Lund, Sweden. (21) Asgard Therapeutics AB, Medicon Village, Lund, Sweden. (22) Department of Clinical Sciences, Division of Oncology and Pathology, Lund University Cancer Center, Lund University, Lund, Sweden. (23) Division of Immuno-Oncology, Lund Stem Cell Center, Lund University, Lund, Sweden; Wallenberg Centre for Molecular Medicine, Lund University, Lund, Sweden; Science for Life Laboratory (SciLifeLab), Lund University, Lund, Sweden. (24) Division of Immuno-Oncology, Lund Stem Cell Center, Lund University, Lund, Sweden; Wallenberg Centre for Molecular Medicine, Lund University, Lund, Sweden; Science for Life Laboratory (SciLifeLab), Lund University, Lund, Sweden; Asgard Therapeutics AB, Medicon Village, Lund, Sweden; CNC - Centre for Neuroscience and Cell Biology, University of Coimbra, Largo Marqus do Pombal, Coimbra, Portugal; CiBB - Centre for Innovative Biomedicine and Biotechnology, University of Coimbra, Coimbra, Portugal. Electronic address: filipe.pereira@med.lu.se.

Author Info: (1) School of Cancer and Pharmaceutical Sciences, King's College London, London SE1 1UL, UK. (2) School of Cancer and Pharmaceutical Sciences, King's College London, London SE1 1UL

Author Info: (1) School of Cancer and Pharmaceutical Sciences, King's College London, London SE1 1UL, UK. (2) School of Cancer and Pharmaceutical Sciences, King's College London, London SE1 1UL, UK. (3) School of Cancer and Pharmaceutical Sciences, King's College London, London SE1 1UL, UK. (4) School of Cancer and Pharmaceutical Sciences, King's College London, London SE1 1UL, UK. (5) School of Cancer and Pharmaceutical Sciences, King's College London, London SE1 1UL, UK. (6) School of Cancer and Pharmaceutical Sciences, King's College London, London SE1 1UL, UK. (7) School of Cancer and Pharmaceutical Sciences, King's College London, London SE1 1UL, UK. (8) School of Cancer and Pharmaceutical Sciences, King's College London, London SE1 1UL, UK. (9) School of Cancer and Pharmaceutical Sciences, King's College London, London SE1 1UL, UK. (10) School of Cancer and Pharmaceutical Sciences, King's College London, London SE1 1UL, UK. (11) School of Cancer and Pharmaceutical Sciences, King's College London, London SE1 1UL, UK. (12) Miltenyi Biotec B.V. & Co. KG, Friedrich-Ebert-Stra§e 68, 51429 Bergisch Gladbach, Germany. (13) Genome Centre, Blizard Institute, Queen Mary University of London, London E1 2AT, UK. (14) Genomics Research Platform, Advanced Therapies Centre, Guy's Hospital, King's College London, London SE1 9RT, UK. (15) Genomics Research Platform, Advanced Therapies Centre, Guy's Hospital, King's College London, London SE1 9RT, UK. (16) School of Cancer and Pharmaceutical Sciences, King's College London, London SE1 1UL, UK. (17) School of Cancer and Pharmaceutical Sciences, King's College London, London SE1 1UL, UK. Electronic address: james.arnold@kcl.ac.uk.

Author Info: (1) T Cells and Cancer, Experimental and Translational Immunology Section, Department for Health Technology, Technical University of Denmark, 2800 Kongens Lyngby, Denmark. Electron

Author Info: (1) T Cells and Cancer, Experimental and Translational Immunology Section, Department for Health Technology, Technical University of Denmark, 2800 Kongens Lyngby, Denmark. Electronic address: krisha@dtu.dk. (2) T Cells and Cancer, Experimental and Translational Immunology Section, Department for Health Technology, Technical University of Denmark, 2800 Kongens Lyngby, Denmark. (3) T Cells and Cancer, Experimental and Translational Immunology Section, Department for Health Technology, Technical University of Denmark, 2800 Kongens Lyngby, Denmark. (4) T Cells and Cancer, Experimental and Translational Immunology Section, Department for Health Technology, Technical University of Denmark, 2800 Kongens Lyngby, Denmark. (5) T Cells and Cancer, Experimental and Translational Immunology Section, Department for Health Technology, Technical University of Denmark, 2800 Kongens Lyngby, Denmark. (6) T Cells and Cancer, Experimental and Translational Immunology Section, Department for Health Technology, Technical University of Denmark, 2800 Kongens Lyngby, Denmark. (7) T Cells and Cancer, Experimental and Translational Immunology Section, Department for Health Technology, Technical University of Denmark, 2800 Kongens Lyngby, Denmark. (8) T Cells and Cancer, Experimental and Translational Immunology Section, Department for Health Technology, Technical University of Denmark, 2800 Kongens Lyngby, Denmark. (9) T Cells and Cancer, Experimental and Translational Immunology Section, Department for Health Technology, Technical University of Denmark, 2800 Kongens Lyngby, Denmark. (10) T Cells and Cancer, Experimental and Translational Immunology Section, Department for Health Technology, Technical University of Denmark, 2800 Kongens Lyngby, Denmark. (11) T Cells and Cancer, Experimental and Translational Immunology Section, Department for Health Technology, Technical University of Denmark, 2800 Kongens Lyngby, Denmark. (12) T Cells and Cancer, Experimental and Translational Immunology Section, Department for Health Technology, Technical University of Denmark, 2800 Kongens Lyngby, Denmark. (13) T Cells and Cancer, Experimental and Translational Immunology Section, Department for Health Technology, Technical University of Denmark, 2800 Kongens Lyngby, Denmark. (14) T Cells and Cancer, Experimental and Translational Immunology Section, Department for Health Technology, Technical University of Denmark, 2800 Kongens Lyngby, Denmark. (15) T Cells and Cancer, Experimental and Translational Immunology Section, Department for Health Technology, Technical University of Denmark, 2800 Kongens Lyngby, Denmark. Electronic address: sirha@dtu.dk.

Author Info: (1) Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. Harvard Medical School, Boston, MA, USA. (2) Department of Medical Oncology, Dana-Farber Cancer I

Author Info: (1) Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. Harvard Medical School, Boston, MA, USA. (2) Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. Harvard Medical School, Boston, MA, USA. (3) Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, USA. (4) Translational Immunogenomics Laboratory, Dana-Farber Cancer Institute, Boston, MA, USA. (5) Broad Institute of MIT and Harvard, Cambridge, MA, USA. (6) Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, USA. (7) Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, USA. (8) Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. (9) Harvard Medical School, Boston, MA, USA. Broad Institute of MIT and Harvard, Cambridge, MA, USA. (10) Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, USA. Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA, USA. (11) Broad Institute of MIT and Harvard, Cambridge, MA, USA. (12) Broad Institute of MIT and Harvard, Cambridge, MA, USA. (13) Broad Institute of MIT and Harvard, Cambridge, MA, USA. (14) Broad Institute of MIT and Harvard, Cambridge, MA, USA. (15) Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. (16) Translational Immunogenomics Laboratory, Dana-Farber Cancer Institute, Boston, MA, USA. (17) Translational Immunogenomics Laboratory, Dana-Farber Cancer Institute, Boston, MA, USA. (18) Translational Immunogenomics Laboratory, Dana-Farber Cancer Institute, Boston, MA, USA. (19) Broad Institute of MIT and Harvard, Cambridge, MA, USA. (20) Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. Centre for Immuno-Oncology, Nuffield Department of Medicine, University of Oxford, Oxford, UK. (21) Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. (22) Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. (23) Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. (24) Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. (25) Broad Institute of MIT and Harvard, Cambridge, MA, USA. (26) Harvard Medical School, Boston, MA, USA. Broad Institute of MIT and Harvard, Cambridge, MA, USA. Krantz Family Center for Cancer Research, Massachusetts General Hospital, Boston, MA, USA. (27) Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. Broad Institute of MIT and Harvard, Cambridge, MA, USA. (28) Translational Immunogenomics Laboratory, Dana-Farber Cancer Institute, Boston, MA, USA. Broad Institute of MIT and Harvard, Cambridge, MA, USA. (29) Translational Immunogenomics Laboratory, Dana-Farber Cancer Institute, Boston, MA, USA. (30) Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, USA. Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA, USA. (31) Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. Harvard Medical School, Boston, MA, USA. (32) Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. Harvard Medical School, Boston, MA, USA. (33) Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. Harvard Medical School, Boston, MA, USA. (34) Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. Harvard Medical School, Boston, MA, USA. (35) Broad Institute of MIT and Harvard, Cambridge, MA, USA. Department of Pathology, Massachusetts General Hospital, Boston, MA, USA. Department of Pathology, Harvard Medical School, Boston, MA, USA. (36) Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. Harvard Medical School, Boston, MA, USA. (37) Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. Harvard Medical School, Boston, MA, USA. Broad Institute of MIT and Harvard, Cambridge, MA, USA. Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA. (38) Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, USA. Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA, USA. (39) Broad Institute of MIT and Harvard, Cambridge, MA, USA. (40) Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. Harvard Medical School, Boston, MA, USA. Translational Immunogenomics Laboratory, Dana-Farber Cancer Institute, Boston, MA, USA. Broad Institute of MIT and Harvard, Cambridge, MA, USA. Section of Computational Biomedicine, Department of Medicine, Boston University School of Medicine, Boston, MA, USA. Department of Medical Education and Biomedical Sciences, Methodist University CFVH School of Medicine, Fayetteville, NC, USA. (41) Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. Panogiotis_Konstantinopoulos@dfci.harvard.edu. Harvard Medical School, Boston, MA, USA. Panogiotis_Konstantinopoulos@dfci.harvard.edu. Mellen and Eisenson Family Center for BRCA and Related Genes, Dana-Farber Cancer Institute, Boston, MA, USA. Panogiotis_Konstantinopoulos@dfci.harvard.edu. (42) Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. Catherine_Wu@dfci.harvard.edu. Harvard Medical School, Boston, MA, USA. Catherine_Wu@dfci.harvard.edu. Broad Institute of MIT and Harvard, Cambridge, MA, USA. Catherine_Wu@dfci.harvard.edu. Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA. Catherine_Wu@dfci.harvard.edu.

Author Info: (1) Surgery Branch, NCI, Bethesda, Maryland, USA. (2) Surgery Branch, NCI, Bethesda, Maryland, USA. (3) Surgery Branch, NCI, Bethesda, Maryland, USA. (4) Surgery Branch, NCI, Bethe

Author Info: (1) Surgery Branch, NCI, Bethesda, Maryland, USA. (2) Surgery Branch, NCI, Bethesda, Maryland, USA. (3) Surgery Branch, NCI, Bethesda, Maryland, USA. (4) Surgery Branch, NCI, Bethesda, Maryland, USA. (5) Surgery Branch, NCI, Bethesda, Maryland, USA. (6) Surgery Branch, NCI, Bethesda, Maryland, USA. (7) Surgery Branch, NCI, Bethesda, Maryland, USA. (8) Surgery Branch, NCI, Bethesda, Maryland, USA. (9) Surgery Branch, NCI, Bethesda, Maryland, USA. (10) Surgery Branch, NCI, Bethesda, Maryland, USA. (11) Surgery Branch, NCI, Bethesda, Maryland, USA. (12) Surgery Branch, NCI, Bethesda, Maryland, USA. (13) Surgery Branch, NCI, Bethesda, Maryland, USA. (14) Surgery Branch, NCI, Bethesda, Maryland, USA. (15) Surgery Branch, NCI, Bethesda, Maryland, USA. (16) Surgery Branch, NCI, Bethesda, Maryland, USA. (17) Surgery Branch, NCI, Bethesda, Maryland, USA. (18) Surgery Branch, NCI, Bethesda, Maryland, USA. (19) Surgery Branch, NCI, Bethesda, Maryland, USA. (20) Systems Biology Center, NHLBI, Bethesda, Maryland, USA. (21) Systems Biology Center, NHLBI, Bethesda, Maryland, USA. (22) Systems Biology Center, NHLBI, Bethesda, Maryland, USA. (23) Surgery Branch, NCI, Bethesda, Maryland, USA. (24) Surgery Branch, NCI, Bethesda, Maryland, USA. (25) Surgery Branch, NCI, Bethesda, Maryland, USA. (26) Surgery Branch, NCI, Bethesda, Maryland, USA. (27) NIDDK, Bethesda, Maryland, USA. (28) NCI/CCR, Bethesda, Maryland, USA. (29) Surgery Branch, NCI, Bethesda, Maryland, USA. (30) Surgery Branch, NCI, Bethesda, Maryland, USA nicholas.klemen@duke.edu.

Author Info: (1) Department of Biochemistry and Molecular Biology, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. ketang@hust.edu.cn. Department of Breast

Author Info: (1) Department of Biochemistry and Molecular Biology, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. ketang@hust.edu.cn. Department of Breast and Thyroid Surgery, Union Hospital, Huazhong University of Science and Technology, Wuhan, China. ketang@hust.edu.cn. (2) Department of Biochemistry and Molecular Biology, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. (3) School of Medicine, Xinxiang University, Xinxiang, China. (4) Department of Biochemistry and Molecular Biology, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. (5) Department of Biochemistry and Molecular Biology, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. (6) Department of Biochemistry and Molecular Biology, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. (7) Department of Biochemistry and Molecular Biology, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. (8) Department of Biochemistry and Molecular Biology, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. (9) Department of Biochemistry and Molecular Biology, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. (10) Department of Biochemistry and Molecular Biology, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. (11) Department of Biochemistry and Molecular Biology, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. (12) Department of Pathology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. (13) Department of Immunology, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. (14) Department of Immunology and State Key Laboratory of Common Mechanism Research for Major Diseases, Institute of Basic Medical Sciences, Institute of Basic Medical Sciences & School of Basic Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China. (15) Department of Immunology and State Key Laboratory of Common Mechanism Research for Major Diseases, Institute of Basic Medical Sciences, Institute of Basic Medical Sciences & School of Basic Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China. (16) Department of Immunology and State Key Laboratory of Common Mechanism Research for Major Diseases, Institute of Basic Medical Sciences, Institute of Basic Medical Sciences & School of Basic Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China. (17) Department of Biochemistry and Molecular Biology, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. tjhuangbo@hotmail.com. Department of Immunology and State Key Laboratory of Common Mechanism Research for Major Diseases, Institute of Basic Medical Sciences, Institute of Basic Medical Sciences & School of Basic Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China. tjhuangbo@hotmail.com.

Author Info: (1) Mass General Brigham Cancer Institute, Boston, MA, USA. (2) Center for Cancer Immuno-Oncology, Center for Cancer Research, National Cancer Institute, National Institutes of Hea

Author Info: (1) Mass General Brigham Cancer Institute, Boston, MA, USA. (2) Center for Cancer Immuno-Oncology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA. (3) Memorial Sloan Kettering Cancer Center, New York, NY, USA. (4) Princess Margaret Cancer Centre, Toronto, Ontario, Canada. (5) AdventHealth Cancer Institute, Orlando, FL, USA. (6) The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA. (7) Institut BergoniŽ, Bordeaux, France. (8) University of Paris Saclay, Gustave Roussy Cancer Center, Villejuif, France. (9) University of Paris Saclay, Gustave Roussy Cancer Center, Villejuif, France. (10) University of Paris Saclay, Gustave Roussy Cancer Center, Villejuif, France. (11) Medical Oncology Department, Vall d'Hebron Hospital Campus and Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. (12) Medical Oncology Department, Vall d'Hebron Hospital Campus and Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. (13) START-FJD, Madrid, Spain. (14) Mass General Brigham Cancer Institute, Boston, MA, USA. (15) Memorial Sloan Kettering Cancer Center, New York, NY, USA. (16) AdventHealth Cancer Institute, Orlando, FL, USA. (17) Department of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania, Philadelphia, PA, USA. Institute for Immunology and Immune Health, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. Parker Institute for Cancer Immunotherapy at University of Pennsylvania, Philadelphia, PA, USA. (18) Center for Cancer Immuno-Oncology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA. (19) Center for Cancer Immuno-Oncology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA. (20) Marengo Therapeutics Inc., Cambridge, MA, USA. (21) Marengo Therapeutics Inc., Cambridge, MA, USA. (22) Marengo Therapeutics Inc., Cambridge, MA, USA. (23) Marengo Therapeutics Inc., Cambridge, MA, USA. (24) Marengo Therapeutics Inc., Cambridge, MA, USA. (25) Marengo Therapeutics Inc., Cambridge, MA, USA. (26) Marengo Therapeutics Inc., Cambridge, MA, USA. (27) Marengo Therapeutics Inc., Cambridge, MA, USA. (28) Marengo Therapeutics Inc., Cambridge, MA, USA. kliu@marengotx.com. (29) Princess Margaret Cancer Centre, Toronto, Ontario, Canada. lillian.siu@uhn.ca. (30) Center for Cancer Immuno-Oncology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA. gulleyj@mail.nih.gov.

Author Info: (1) Medical College of Wisconsin, Milwaukee, WI, USA. george.ben@mayo.edu. Mayo Clinic Comprehensive Cancer Center, Rochester, MN, USA. george.ben@mayo.edu. (2) Dana Farber Cancer

Author Info: (1) Medical College of Wisconsin, Milwaukee, WI, USA. george.ben@mayo.edu. Mayo Clinic Comprehensive Cancer Center, Rochester, MN, USA. george.ben@mayo.edu. (2) Dana Farber Cancer Institute, Boston, MA, USA. (3) Northwell Health Cancer Institute, New Hyde Park, NY, USA. (4) City of Hope, Duarte, CA, USA. (5) Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, USA. (6) Samuel Oschin Cancer Center, Cedars Sinai, Los Angeles, CA, USA. (7) Moffitt Cancer Center, Tampa, FL, USA. (8) University of California, Irvine, Orange, CA, USA. (9) Mayo Clinic, Phoenix, AZ, USA. (10) Vanderbilt-Ingram Cancer Center, Vanderbilt Health, Nashville, TN, USA. (11) Weill-Cornell Medicine, New York, NY, USA. NYU Langone Health, New York, NY, USA. (12) City of Hope, Duarte, CA, USA. Weill-Cornell Medicine, New York, NY, USA. (13) University of Colorado School of Medicine, Aurora, CO, USA. (14) Sarah Cannon Research Institute, Nashville, TN, USA. (15) University of Iowa, Iowa City, IA, USA. (16) Mass General Hospital, Boston, MA, USA. (17) University of Pennsylvania, Philadelphia, PA, USA. (18) University of Florida, Gainesville, FL, USA. (19) UT Southwestern, Dallas, TX, USA. (20) Ochsner Health, New Orleans, LA, USA. (21) Lehigh Valley Topper Cancer Institute, Jefferson Health, Allentown, PA, USA. (22) Center for International Blood and Marrow Transplant Research, NMDP, Minneapolis, MN, USA. (23) Elicio Therapeutics, Boston, MA, USA. (24) Elicio Therapeutics, Boston, MA, USA. (25) Elicio Therapeutics, Boston, MA, USA. (26) Elicio Therapeutics, Boston, MA, USA. (27) Elicio Therapeutics, Boston, MA, USA. (28) Elicio Therapeutics, Boston, MA, USA. (29) Elicio Therapeutics, Boston, MA, USA. (30) Elicio Therapeutics, Boston, MA, USA. (31) Elicio Therapeutics, Boston, MA, USA. (32) Elicio Therapeutics, Boston, MA, USA. (33) Elicio Therapeutics, Boston, MA, USA. chris.haqq@elicio.com. (34) University of Texas, MD Anderson Cancer Center, Houston, TX, USA. (35) University of California, Los Angeles, Los Angeles, CA, USA. (36) Memorial Sloan Kettering Cancer Center, New York, NY, USA. oreillye@mskcc.org.